Status:
NOT_YET_RECRUITING
Second Line Endovascular Treatment in Acute DVT
Lead Sponsor:
Rush University Medical Center
Conditions:
Deep Venous Thrombosis
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The goal of this study is to fill the paucity of second line endovascular treatment for acute deep venous thrombus (DVT) by using catheter-directed thrombolysis (CDT) and mechanical thrombectomy (MT) ...
Detailed Description
The incidence of deep vein thrombosis (DVT) annually is documented to be between 45 and 117 cases per 100,000 individuals. The disease markedly impairs patient well-being, leading to symptoms such as ...
Eligibility Criteria
Inclusion
- Patients over 18 years of age
- Patients who have diagnosis of acute femoropopliteal acute deep venous thrombus
- Patients eligible for anticoagulation treatment
Exclusion
- Patients under 18 years of age
- Patients over 75 years of age
- Symptoms starting date of more than 14 days
- Patients who have contraindication for anticoagulation treatment
- Patients who have high bleeding risk (more than 2 of the following risk factors):
- Age \>65 years
- Previous bleeding
- Cancer
- Metastatic cancer
- Renal failure
- Liver failure
- Thrombocytopenia
- Previous stroke
- Diabetes
- Anemia
- Antiplatelet therapy
- Poor anticoagulant control
- Comorbidity and reduced functional capacity
- Recent surgery in 30 days
- Frequent falls
- Hemodynamically unstable patients
- Patients having severe swelling and pain, cyanosis, and absent pulses consistent with compartment syndrome.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06486181
Start Date
December 1 2025
End Date
December 30 2028
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RUSH University Medical Center
Chicago, Illinois, United States, 60612